Table 3.

Clinical outcomes in FST responders and FST non-responders using urine output greater than or less than 600 mL, respectively.

Outcome	All patients (n=200)	FST Responders* (n= 93)	FST Non-responders** (n= 107)	p-Value
DGF (HD within one week post transplantation)	94 (47%)	22 (23%)	72 (77%)	<0.001
Lowest serum potassium first 24h, mEq/L	4.1 (3.8–4.5)	4.1 (3.8–4.6)	4.1 (3.8–4.5)	0.98
Lowest MAP first 24h, mmHg	78 (±16)	82 (±16)	75 (±15)	0.006
Graft Loss, n (%)	9 (5%)	3 (3%)	6 (6%)	0.31
Graft loss due to rejection (acute or chronic)	4 (2%)	2 (2%)	2 (2%)	1.0
Length of Hospital stay, days	10 (7–15)	8 (6–11)	12 (9–17)	<0.001
Death, n (%)	7 (4%)	2 (2%)	5 (5%)	0.25
Death with graft function, n (%)	5 (3%)	2 (2%)	3 (3%)	0.65

Continuous variables are presented as mean (± standard deviation) or median (interquartile range) unless otherwise stated. Parametric data were compared with an unpaired t-test. Non-parametric data were compared using the Wilcoxon–Mann–Whitney test. Binomial data were compared using a Persons coefficient.

^*UO > 600 mL 6 h post transplantation.

^**UO < 600 mL 6 h post transplantation.

FST: Furosemide stress test; K+: potassium; MAP: mean arterial pressure; HD: dialysis; SE: standard error.